Novel technology to develop non-transmissible live influenza virus vaccines through alterations in M2/M42 ion channel expression
Preprint in bioRxiv (April 2023)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Preprint in bioRxiv (April 2023)
Article in Vaccines (March 2023)
Article in Frontiers in Immunology (April 2019)